BIANCA WALDSCHMIDT: Open Payments
NPI 1437651692 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 75 payments from 14 companies in 2025. Trend: 2023 $1,922 · 2024 $1,103 · 2025 $1,759
Food & beverage: $1,474Education: $285
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $310 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $308 |
| Galderma Laboratories, L.P. | 13 | $246 |
| Regeneron Healthcare Solutions, Inc. | 11 | $231 |
| UCB, Inc. | 7 | $207 |
| ABBVIE INC. | 6 | $203 |
| Amgen Inc. | 3 | $63 |
| GENZYME CORPORATION | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| PFIZER INC. | 1 | $23 |
Products named: NEMLUVIO, DUPIXENT, Bimzelx, SKYRIZI, ILUMYA, Rhapsido, COSENTYX, OTEZLA.
Industry payments across IA — which companies pay providers there.
